The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance
Diana M. Willmes1,2,
,
Stephen L. Helfand3,
,
Andreas L. Birkenfeld1,2,
,
-
1 Section of Metabolic Vascular Medicine, Medical Clinic III, Dresden University School of Medicine, Technische Universität Dresden, Dresden, Germany
-
2 Paul Langerhans Institute Dresden (PLID), German Center for Diabetes Research (DZD), Dresden, Germany
-
3 Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA
Received: February 19, 2016
Published: February 23, 2016
https://doi.org/10.18632/aging.100907
How to Cite
Cite this Article
How to cite
Willmes DM, Helfand SL, Birkenfeld AL, . The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance. Aging (Albany NY). 2016 Feb 23;
8:208-209
.
https://doi.org/10.18632/aging.100907
Copy or Download citation:
Select the format you require from the list below
Click to copy this citation from the text box above or download the citation:
Citation |
Citation & Abstract
Copyright: © 2016 Willmes et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
